Overview

Relative Bioavailability Study to Compare Inhalation of Terbutaline Sulphate 1,5mg Via Turbuhaler M3 With Turbuhaler M2

Status:
Completed

Trial end date:
2014-11-01

Target enrollment:

Participant gender:

Summary

Relative bioavailability study to compare inhalation of Terbutaline Sulphate 1,5mg via current version of Turbuhaler with inhalation via a new version

Phase:

Phase 1

Details

Lead Sponsor:

AstraZeneca

Treatments:

Terbutaline